Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 8:10.1111/jgs.18116. Online ahead of print. doi: 10.1111/jgs.18116

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

Antipsychotic, antianxiety, antidepressant, hypnotic, and opioid use among Michigan long‐stay nursing home residents with Alzheimer's disease and related dementias (ADRD), January 1, 2018–June 30, 2021. The percentage of monthly medication [i.e., antidepressant, opioid, antianxiety, antipsychotic, and hypnotic] use was examined on all Minimum Data Set assessments per resident for a given month. Opioid medication use measurement started in March 2018. Residents with Huntington's disease, Tourette syndrome, and schizophrenia were excluded. Enlargement portrays the monthly percentage of antidepressant, opioid, antianxiety, and antipsychotic medication use during COVID‐19 among long‐stay nursing home residents with ADRD.